Chitrangda Singh

Development of novel aspartic acid-based calcium bio-MOF designed for the management of severe bleeding

Chandan Bhogendra Jha, Chitrangda Singh, Raunak Varshney et al. · Materials Advances · 2023 · 13 citations · Full text

Medicine, Biochemistry, Medicinal Chemistry +14

Novel amino-acid based metal–organic frameworks (Bio-MOFs) as hemostatic agents: Unveiling promising frontiers in hemostasis

Chandan Bhogendra Jha, Chitrangda Singh, Kuntal Manna et al. · Medical Hypotheses · 2023 · 12 citations

Medicine, Medicinal Chemistry, Pharmacology +16

Tranexamic acid (class I drug) reduced and capped gold nanoparticles as a potential hemostatic agent with enhanced performance

Chandan Bhogendra Jha, Chitrangda Singh, Parag R. Patil et al. · Nanotechnology · 2023 · 10 citations · Full text

Medicine, Hematology, Pharmacology +17

Synthesis and evaluation of curcumin reduced and capped gold nanoparticles as a green diagnostic probe with therapeutic potential

Chandan Bhogendra Jha, Chitrangda Singh, Jaspreet Kaur Randhawa et al. · Colloids and Surfaces B Biointerfaces · 2024 · 10 citations

Natural Sciences, Materials Science, Pharmaceutics +16